Search
Search
Arsham Sheybani, MD; and Murray Johnstone, MD
Show Description +
Murray Johnstone, MD, talks with Arsham Sheybani, MD, about some common misconceptions about the trabecular meshwork. Dr. Johnstone says that if surgeons had a better understanding of the trabecular meshwork, they could be more innovative and willing to expand their treatment approaches.
Posted: 6/28/2022
Arsham Sheybani, MD; and Murray Johnstone, MD
Murray Johnstone, MD, talks with Arsham Sheybani, MD, about some common misconceptions about the trabecular meshwork. Dr. Johnstone says that if surgeons had a better understanding of the trabecular meshwork, they could be more innovative and willing to expand their treatment approaches.
Posted: 6/28/2022
Combined Canaloplasty and Cataract Surgery: Considerations for Implementation and Adoption
The Opportunity in Canaloplasty
Restoring the Anatomy with Canaloplasty
Understanding the Mechanisms Associated With Canaloplasty
Case Review: Canaloplasty in a Case of Steroid-Induced Uncontrolled Ocular Hypertension
The Versatility of Standalone Canaloplasty
Targeting and Treating All Glaucoma Anatomy with Canaloplasty
Pros Versus Cons of Preserving Trabecular Meshwork in the Treatment of Glaucoma: Part 2
Pros Versus Cons of Preserving Trabecular Meshwork in the Treatment of Glaucoma: Part 1
About Nova Eye Medical
WE ARE NOVA EYE MEDICAL
With a legacy that spans more than 30 years in ophthalmology, Nova Eye Medical designs, develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies. Underpinning each of these technologies is our commitment to advance clinical outcomes and improve patient quality of life.
Visit Us Online: nova-eye.com
Follow Nova Eye Medical
The Nova Eye iTrack™ Advance is indicated for fluid infusion or aspiration during surgery.
The Nova Eye iTrack™ Advance is indicated for the cutting or disruption of the trabecular meshwork during goniotomy procedures.*
The Nova Eye iTrack™ Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma.
* The iTrack™ Advance cutting function (goniotomy) is a Class 1 510(k) exempt device function that is not specifically indicated for the reduction of intraocular pressure (IOP) or the treatment of open-angle glaucoma.
